Scandion Oncology A/S (SCOL) — Net Asset Momentum
Scandion Oncology A/S (SCOL) recorded a net asset momentum of -73.4% as of December 2024, with net assets of Skr8.27 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See SCOL defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Scandion Oncology A/S Net Asset Momentum (2017–2024)
This chart tracks Scandion Oncology A/S's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -73.4%, with net assets of Skr8.27 Million SEK as of December 2024. Read Scandion Oncology A/S debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Scandion Oncology A/S (2017–2024)
The table below shows the complete annual net asset history for Scandion Oncology A/S from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Scandion Oncology A/S market cap and net worth.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr8.27 Million | Skr18.28 Million | Skr10.01 Million | ▼ -73.4% |
| 2023 | Skr31.12 Million | Skr34.56 Million | Skr3.44 Million | ▼ -55.7% |
| 2022 | Skr70.33 Million | Skr89.40 Million | Skr19.07 Million | ▼ -32.7% |
| 2021 | Skr104.54 Million | Skr116.22 Million | Skr11.68 Million | ▼ -32.9% |
| 2020 | Skr155.87 Million | Skr186.41 Million | Skr30.54 Million | ▲ +749.9% |
| 2019 | Skr18.34 Million | Skr19.90 Million | Skr1.56 Million | ▲ +45.9% |
| 2018 | Skr12.57 Million | Skr13.56 Million | Skr992.64K | ▲ +765.3% |
| 2017 | Skr1.45 Million | Skr1.96 Million | Skr509.02K | — |